OriCiro Genomics
Tokyo
About OriCiro Genomics
OriCiro Genomics creates a better bioeconomy with innovative genome technologies. The company is a pioneer in cell-free synthesis and amplification of genome-scale large DNA for synthetic biology. The company creates a technology that covers "DNA assembly" and "circular DNA amplification", allowing to construct large circular DNA molecules without relying on conventional biological cloning.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $12.7M
- Funding stage: M&A
- Last round: Series B (Jun 2022)
- Website: oriciro.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/oriciro-genomics-92341 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.